151 related articles for article (PubMed ID: 21696398)
1. Screening of subfertile men for testicular carcinoma in situ by an automated image analysis-based cytological test of the ejaculate.
Almstrup K; Lippert M; Mogensen HO; Nielsen JE; Hansen JD; Daugaard G; Jørgensen N; Foged NT; Skakkebaek NE; Rajpert-De Meyts E
Int J Androl; 2011 Aug; 34(4 Pt 2):e21-30; discussion e30-1. PubMed ID: 21696398
[TBL] [Abstract][Full Text] [Related]
2. A subfertile patient diagnosed with testicular carcinoma in situ by immunocytological staining for AP-2gamma in semen samples: case report.
Hoei-Hansen CE; Rajpert-De Meyts E; Carlsen E; Almstrup K; Leffers H; Skakkebaek NE
Hum Reprod; 2005 Mar; 20(3):579-82. PubMed ID: 15650041
[TBL] [Abstract][Full Text] [Related]
3. Noninvasive detection of testicular carcinoma in situ in semen using OCT3/4.
van Casteren NJ; Stoop H; Dohle GR; de Wit R; Oosterhuis JW; Looijenga LH
Eur Urol; 2008 Jul; 54(1):153-8. PubMed ID: 17996359
[TBL] [Abstract][Full Text] [Related]
4. Application of stem cell markers in search for neoplastic germ cells in dysgenetic gonads, extragonadal tumours, and in semen of infertile men.
Hoei-Hansen CE
Cancer Treat Rev; 2008 Jun; 34(4):348-67. PubMed ID: 18289797
[TBL] [Abstract][Full Text] [Related]
5. Towards a non-invasive method for early detection of testicular neoplasia in semen samples by identification of fetal germ cell-specific markers.
Hoei-Hansen CE; Carlsen E; Jorgensen N; Leffers H; Skakkebaek NE; Rajpert-De Meyts E
Hum Reprod; 2007 Jan; 22(1):167-73. PubMed ID: 16920726
[TBL] [Abstract][Full Text] [Related]
6. A novel double staining strategy for improved detection of testicular carcinoma in situ cells in human semen samples.
Nielsen JE; Kristensen DM; Almstrup K; Jørgensen A; Olesen IA; Jacobsen GK; Horn T; Skakkebaek NE; Leffers H; Rajpert-De Meyts E
Andrologia; 2012 Apr; 44(2):78-85. PubMed ID: 21486421
[TBL] [Abstract][Full Text] [Related]
7. Testicular carcinoma in situ in subfertile Danish men.
Olesen IA; Hoei-Hansen CE; Skakkebaek NE; Petersen JH; Rajpert-De Meyts E; Jørgensen N
Int J Androl; 2007 Aug; 30(4):406-11; discussion 412. PubMed ID: 17705813
[TBL] [Abstract][Full Text] [Related]
8. [Early detection of a contralateral second carcinoma in patients with testicular tumors caused by testicular carcinoma in situ].
Kleinschmidt K; Weissbach L; Holstein AF
Urologe A; 1989 Sep; 28(5):281-4. PubMed ID: 2573191
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of testicular biopsies for carcinoma in situ: immunohistochemistry is mandatory.
van Casteren NJ; de Jong J; Stoop H; Steyerberg EW; de Bekker-Grob EW; Dohle GR; Oosterhuis JW; Looijenga LH
Int J Androl; 2009 Dec; 32(6):666-74. PubMed ID: 18798762
[TBL] [Abstract][Full Text] [Related]
10. Clinical and biological significance of carcinoma in situ of the testis.
Jørgensen N; Müller J; Giwercman A; Skakkebaek NE
Cancer Surv; 1990; 9(2):287-302. PubMed ID: 1964624
[TBL] [Abstract][Full Text] [Related]
11. Carcinoma in situ of the testis. Detection of malignant germ cells in seminal fluid by means of in situ hybridization.
Giwercman A; Hopman AH; Ramaekers FC; Skakkebaek NE
Am J Pathol; 1990 Mar; 136(3):497-502. PubMed ID: 2316622
[TBL] [Abstract][Full Text] [Related]
12. Epidemiological and clinical aspects of carcinoma in situ of the testis.
Giwercman A; von der Maase H; Skakkebaek NE
Eur Urol; 1993; 23(1):104-10; discussion 111-4. PubMed ID: 8477770
[TBL] [Abstract][Full Text] [Related]
13. Immunostaining for placental alkaline phosphatase on fine-needle aspiration specimens to detect noninvasive testicular cancer: a prospective evaluation in cryptorchid men.
Tavolini IM; Bettella A; Boscolo Berto R; Bassi PF; Longo R; Menegazzo M; Garolla A; Foresta C
BJU Int; 2006 May; 97(5):950-4. PubMed ID: 16643476
[TBL] [Abstract][Full Text] [Related]
14. Diagnosis of contralateral testicular intraepithelial neoplasia (TIN) in patients with testicular germ cell cancer: systematic two-site biopsies are more sensitive than a single random biopsy.
Dieckmann KP; Kulejewski M; Pichlmeier U; Loy V
Eur Urol; 2007 Jan; 51(1):175-83; discussion 183-5. PubMed ID: 16814456
[TBL] [Abstract][Full Text] [Related]
15. A pathologist's view on the testis biopsy.
Oosterhuis JW; Stoop H; Dohle G; Boellaard W; van Casteren N; Wolffenbuttel K; Looijenga LH
Int J Androl; 2011 Aug; 34(4 Pt 2):e14-9; discussion e20. PubMed ID: 21790650
[TBL] [Abstract][Full Text] [Related]
16. [Carcinoma in situ of the testis: clinical significance, diagnosis and therapy].
Dieckmann KP; Loy V; Huland H
Urologe A; 1989 Sep; 28(5):271-80. PubMed ID: 2554553
[TBL] [Abstract][Full Text] [Related]
17. Value of testicular biopsy in diagnosing carcinoma in situ testis.
Berthelsen JG; Skakkebaek NE
Scand J Urol Nephrol; 1981; 15(3):165-8. PubMed ID: 7323735
[TBL] [Abstract][Full Text] [Related]
18. Sperm concentration, testicular volume and age predict risk of carcinoma in situ in contralateral testis of men with testicular germ cell cancer.
Rud CN; Daugaard G; Rajpert-De Meyts E; Skakkebæk NE; Petersen JH; Jørgensen N
J Urol; 2013 Dec; 190(6):2074-80. PubMed ID: 23770148
[TBL] [Abstract][Full Text] [Related]
19. Human testicular (non)seminomatous germ cell tumours: the clinical implications of recent pathobiological insights.
Looijenga LH
J Pathol; 2009 Jun; 218(2):146-62. PubMed ID: 19253916
[TBL] [Abstract][Full Text] [Related]
20. Testicular biopsy for early cancer detection--objectives, technique and controversies.
Dieckmann KP; Kulejewski M; Heinemann V; Loy V
Int J Androl; 2011 Aug; 34(4 Pt 2):e7-13. PubMed ID: 21615417
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
